[23 October 2013]
Products Affected - Description
Phenobarbital tablets, West-Ward
15 mg, 500 count (NDC 00143-1445-05)
30 mg, 500 count (NDC 00143-1450-05)
60 mg, 500 count (NDC 00143-1455-05)
100 mg, 500 count (NDC 00143-1458-05)
Reason for the Shortage
West-Ward states the reason for the shortage is manufacturing delay.
Phenobarbital tablets, Qualitest
16.2 mg, 100 count (NDC 00603-5165-21)
16.2 mg, 1000 count (NDC 00603-5165-32)
32.4 mg, 30 count (NDC 00603-5166-16)
32.4 mg, 60 count (NDC 00603-5166-20)
32.4 mg, 90 count (NDC 00603-5166-02)
32.4 mg, 100 count (NDC 00603-5166-21)
32.4 mg, 120 count (NDC 00603-5166-22)
32.4 mg, 1000 count (NDC 00603-5166-32)
64.8 mg, 100 count (NDC00603-5167-21)
64.8 mg, 1000 count (NDC00603-5167-32)
97.2 mg, 100 count (NDC00603-5168-21)
97.2 mg, 1000 count (NDC00603-5168-32)
Estimated Resupply Dates
West-Ward has all phenobarbital tablets on back order and the company estimates a release date of 2nd quarter 2014.
October 23, 2013; October 11, 2013, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins